Global Pets External Medicine Market Size By Type (Injection, Unguent), By Application (Dogs, Cats), By Region, And Segment Forecasts, 2023 to 2032

The Global Pets External Medicine Market was valued at USD 4.3 billion in 2023 and is projected to surpass USD 7.9 billion by 2031, expanding at a CAGR of 7.8% during the forecast period of 2023–2031. The rising pet ownership worldwide, increasing awareness about pet health, and the surge in zoonotic diseases are key factors propelling the demand for external pet medicines such as flea and tick repellents, anti-fungal sprays, medicated shampoos, and spot-on treatments.

Pet parents are becoming increasingly proactive about preventive healthcare, driving growth in the market. Additionally, veterinary recommendations and e-commerce availability have expanded accessibility to advanced topical treatments.

Drivers:

1. Rising Pet Adoption and Humanization of Pets:

Globally, there is a marked rise in pet ownership, especially cats and dogs. Pet owners are spending more on healthcare, with a focus on dermatological and parasitic treatments.

2. Surge in Parasitic Infestations:

With climate change expanding the habitat range of fleas and ticks, there is a growing need for preventive and curative topical medications. Regular use of spot-on treatments and insecticidal collars has become standard in pet care routines.

3. Growth in E-commerce Channels:

Online veterinary pharmacies and pet product platforms have made external medications widely accessible, encouraging recurring purchases and improved compliance among pet owners.

Restraints:

1. Side Effects and Product Sensitivities:

Some pets may experience adverse reactions such as skin irritation or allergic responses to topical medications, which can deter use.

2. Limited Awareness in Emerging Markets:

In developing regions, awareness about preventive pet care is still low, limiting adoption despite the growing pet population.

Opportunity:

1. Innovation in Natural and Herbal Formulations:

Consumer preference is shifting toward organic and chemical-free external treatments, presenting opportunities for companies to invest in R&D of plant-based medicines.

2. Expansion in Untapped Markets:

Emerging economies with growing urbanization and disposable incomes offer potential for market penetration with the right educational and promotional strategies.

Market by System Type Insights:

The Spot-on Treatment segment dominated the market in 2023 due to its ease of application, high efficacy, and long-lasting effects against fleas, ticks, and mites. The medicated shampoo segment is also witnessing strong growth driven by increasing cases of fungal infections and skin conditions among pets.

Market by End-use Insights:

Veterinary Clinics emerged as the largest end-use segment in 2023, driven by professional guidance and trust in prescribed products. Home Care/Direct-to-Consumer is expected to grow rapidly owing to the convenience of online shopping and increased self-care practices among pet owners.

Market by Regional Insights:

North America led the market in 2023 with a substantial share, supported by high pet ownership rates, strong veterinary infrastructure, and product availability. Asia-Pacific is projected to exhibit the highest growth rate through 2031 due to rising disposable incomes, rapid urbanization, and evolving pet care practices in countries such as China and India.

Competitive Scenario:

Key players in the Global Pets External Medicine Market include Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim, Virbac, Vetoquinol, Bayer AG, Ceva Santé Animale, PetIQ Inc., Merck & Co., Inc., and TropiClean. These companies focus on product innovation, acquisitions, and geographical expansion.

Key Market Developments:

In 2024, Zoetis Inc. launched a new range of plant-based flea and tick repellents for cats and dogs with extended-release technology.

In 2023, Elanco partnered with leading retail chains in Europe to expand access to its external parasite control products.

In 2022, Virbac introduced its new anti-fungal topical line specifically formulated for long-haired breeds.

Scope of Work – Global Pets External Medicine Market

FAQs:

1) What is the current market size of the Global Pets External Medicine Market?

The Global Pets External Medicine Market was valued at USD 4.3 billion in 2023.

2) What is the major growth driver of the Global Pets External Medicine Market?

The major growth driver is the rising adoption of pets and increasing cases of parasitic infestations requiring preventive external treatments.

3) Which is the largest region during the forecast period in the Global Pets External Medicine Market?

North America is the largest region due to high awareness, spending capacity, and availability of products.

4) Which segment accounted for the largest market share in the Global Pets External Medicine Market?

The Spot-on Treatment segment held the largest share in 2023.

5) Who are the key market players in the Global Pets External Medicine Market?

Key players include Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim, Virbac, and Merck & Co., Inc.